OxyNorm® Capsules (Immediate-Release) Pharmacokinetic (PK) Study

NCT01643772 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
61
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Mundipharma (China) Pharmaceutical Co. Ltd